The FDA granted quick observe designation to Abdera Therapeutics’ ABD-147 as therapy for intensive stage small cell lung most cancers (SCLC) who've progressed...
CStone Prescription drugs (HK:2616) has launched an replace.
CStone Prescription drugs has granted unique promotion rights for AYVAKIT, a precision remedy for gastrointestinal stromal...